Community Pharmacy England (CPE) - News updates


Community Pharmacy England begins early engagement for 2027 elections

Community Pharmacy England is beginning early engagement activity to support preparation for the next round of elections to its Committee, due to take place in autumn 2026 for the 2027–2031 term.  As part of this, we will shortly write to pharmacy owners in the ‘10+ multiple (non-CCA)’ category, asking them to review their NHS-held details and confirm [...] The post Community Pharmacy England begins early engagement for 2027 elections appeared first on Community Pharmacy England.

Nominations open for East and North Midlands Representative

Nominations are now being sought as part of the mid-term election process for an ‘Independent regional representative’ for Community Pharmacy England’s East and North Midlands region.   Interested and eligible LPC members or officers in the CPE East and North Midlands region have until 2nd June 2026 to submit their (formal) nomination.  The following briefing sets out the election process:  Guide to the Regional Representative Election for the East and North Midlands Region  [...] The post Nominations open for East and North Midlands Representative appeared first on Community Pharmacy England.

Medicine supply Notification: Trurapi® (insulin aspart) 100units/ml solution for injection 3ml pre-filled Solostar pens

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Trurapi® (insulin aspart) 100units/ml solution for injection 3ml pre-filled Solostar pens. MSN/2026/024 Tier 2 – Medium impact Date of issue: 18 May 2026 Trurapi® (insulin aspart) 100units/ml solution for injection 3ml pre-filled Solostar pens are in limited supply until late May [...] The post Medicine supply Notification: Trurapi® (insulin aspart) 100units/ml solution for injection 3ml pre-filled Solostar pens appeared first on Community Pharmacy England.

NMS myth busting series (#3)

View the first article on NMS myth busting View the second article on NMS myth busting The post NMS myth busting series (#3) appeared first on Community Pharmacy England.

May 2026 Price Concessions 1st Update

The Department of Health and Social Care (DHSC) has today (15/05/2026) confirmed the following initial list of price concessions for May 2026: Drug Pack size Price concession Aspirin 75mg dispersible tablets 28 £2.83 Aspirin 75mg dispersible tablets 100 £10.10 Aspirin 75mg gastro-resistant tablets 28 £2.15 Benzydamine 0.15% oromucosal spray sugar free 30 £1.60 Captopril 25mg tablets [...] The post May 2026 Price Concessions 1st Update appeared first on Community Pharmacy England.

NMS myth busting series (#2)

View the first article on NMS myth busting The post NMS myth busting series (#2) appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH)

MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH) DMRC reference number: DMRC- 39439934 Date issued: 14 May 2026 Fresenius Medical Care Deutschland GmbH have identified an error in the Braille printed on the outer label. Marketing Authorisation Holder: Fresenius Medical Care Deutschland GmbH [...] The post MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH) appeared first on Community Pharmacy England.

NMS myth busting series (#1)

    The post NMS myth busting series (#1) appeared first on Community Pharmacy England.

We’re coming to a town near you

Community Pharmacy England’s annual regional roadshow series returns in less than a month, kicking off with events in Yorkshire & the North East in the first week of June. The series of interactive evening sessions will bring local pharmacies together with the people negotiating on their behalf to talk openly about funding, the challenges facing [...] The post We’re coming to a town near you appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd)

MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) Drug alert number: EL(26)A/23 Date issued: 11 May 2026 Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets. DMRC reference number: DMRC- 39394163 Marketing Authorisation Holder: Milpharm Limited Medicine Details Product name: [...] The post MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) appeared first on Community Pharmacy England.